An Australian stem cell and regenerative medicine company

ASX Announcements

05 Dec 2019 Cymerus MSCs Effective in Preclinical Model of Sepsis
27 Nov 2019 Results of Annual General Meeting
27 Nov 2019 Cynata Annual General Meeting Presentation
27 Nov 2019 Chairman's 2019 AGM Address
25 Nov 2019 CYP Files Application to Commence Phase 2 CLI Clinical Trial
18 Nov 2019 Appendix 3Y-Dr Paul Wotton
18 Nov 2019 Notification of Expiry of Unlisted Options
12 Nov 2019 Appendix 3Y-Mr Peter Webse
12 Nov 2019 Appendix 3Y-Dr Ross Macdonald
12 Nov 2019 Appendix 3Y-Dr Paul Wotton
12 Nov 2019 Cleansing Notice
12 Nov 2019 Appendix 3B-Exercise of Options
30 Oct 2019 Cynata Corporate Presentation
28 Oct 2019 Cynata Awarded Grant for Coronary Artery Disease Study
25 Oct 2019 Notice of Allowance from CIPO for Patent Application
24 Oct 2019 Annual Report to shareholders
24 Oct 2019 Notice of Annual General Meeting/Proxy Form
24 Oct 2019 September 2019 Quarterly Report
17 Oct 2019 Cynata & Sumitomo Withdraw from Acquisition Discussions
14 Oct 2019 Receipt of notice under section 249N of the Corporations Act
03 Oct 2019 CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial
27 Sep 2019 Notification of 2019 Annual General Meeting Date
26 Sep 2019 Cynata Receives US$3 million Fujifilm License Fee
18 Sep 2019 Cleansing Notice
18 Sep 2019 Appendix 3B-Exercise of Options
17 Sep 2019 Fujifilm Exercises License Option in GvHD
09 Sep 2019 Expiry of Voluntary Escrow Arrangement
04 Sep 2019 Cynata transplant rejection study accepted for publication
03 Sep 2019 Cleansing Notice
03 Sep 2019 Appendix 3B-Exercise of Options
27 Aug 2019 Cleansing Notice
27 Aug 2019 Appendix 3B-Exercise of Options
23 Aug 2019 Appendix 4G
23 Aug 2019 Appendix 4E & Annual Report
15 Aug 2019 Cleansing Notice
15 Aug 2019 Appendix 3B-Exercise of Options
15 Aug 2019 Update on Discussions with Sumitomo and Fujifilm
02 Aug 2019 Cleansing Notice
02 Aug 2019 Appendix 3B-Exercise of Options
24 Jul 2019 Response to ASX Aware Query
19 Jul 2019 Response to ASX Price and Volume Query
19 Jul 2019 Cynata confirms receipt of indicative non-binding proposal
17 Jul 2019 Trading Halt
04 Jul 2019 2019 Quarterly Report
30 May 2019 Cynata's Cymerus Technology Featured in ISCT Presentations
20 May 2019 Appendix 3Z-Dr John Chiplin
20 May 2019 Appendix 3X-Dr Geoff Brooke
20 May 2019 Appendix 3B
20 May 2019 Cynata Strengthens Board & Executive Management Team
07 May 2019 Appendix 3Y-Dr John Chiplin